LTR promoter, a process that requires binding of Tat to the TAR bulge and of cyclin T to the TAR loop ( Figure  1 ). The cyclin T-associated CDK9 kinase then induces phosphorylation of the CTD of Pol II, and perhaps other pol II-associated proteins, leading to a transition from nonprocessive to processive transcription.
The mechanism of transcription activation of the HIV-1 LTR by Tat may therefore be close to resolution. Remaining questions include whether the Pol II CTD is the only target for P-TEFb and whether other P-TEFb subunits play a critical role in this process. It is also interesting to speculate as to why the HIV-1 LTR has evolved to promote the initiation of almost entirely nonprocessive transcription complexes that must then be rescued by Tat, when transcription complexes initiated by LTRs found in most other retroviruses elongate effectively without such rescue. While it is tempting to suggest that this property may somehow facilitate the establishment of HIV-1 latency, this must be viewed as little more than speculation at present. 
Rev: Nuclear RNA Export Factor
The large majority of genes in higher eukaryotes exist in the form of multiple coding exons separated by nonby DRB, a nucleoside analog that functions both as a selective kinase inhibitor and as an inhibitor of transcripcoding, intronic regions. These genes are therefore transcribed in the form of pre-mRNAs that must be extention elongation by Pol II (Yang et al., 1996) .
A critical finding in support of the hypothesis that sively spliced before the mature mRNA, encoding the relevant protein product, is ready for translation. BeTat acted at the level of CTD phosphorylation was the observation that immunoprecipitation of Tat resulted in cause these pre-mRNA intermediates would encode useless or even deleterious proteins if available to the the specific coimmunoprecipitation of a CTD kinase of ‫24ف‬ kDa (Yang et al., 1996) . Research into factors incytoplasmic translational machinery, the eukaryotic cell has evolved mechanisms to retain incompletely spliced volved in transcription elongation in Drosophila had meanwhile identified an essential multicomponent facRNAs in the nucleus until splicing is complete. While the mechanisms that maintain this segregation remain tor, termed positive transcription elongation factor b (P-TEFb), that included a novel CTD kinase with homolto be fully elucidated, this is likely to involve the recognition of unused 5Ј splice sites by splicing commitment ogy to cyclin-dependent kinases (CDKs) (Zhu et al., 1997) . Identification of the human homolog of this profactors such as the U1 small nuclear ribonucleoprotein particle and members of the serine-arginine-rich class tein, now called CDK9, revealed that this was also ‫24ف‬ kDa in size. It was rapidly demonstrated that the kinase of splicing factors. While the nuclear retention of incompletely spliced that associates with Tat in vivo was indeed CDK9 and that CDK9 mutants lacking kinase activity could selecRNAs is undoubtedly benefical to the host cell, this presents retroviruses in general, and complex retroviruses tively inhibit Tat function (Zhu et al., 1997) .
While the identification of CDK9 as a critical mediator in particular, with a serious problem (reviewed by Cullen, 1995) . Because HIV-1 contains only the single LTR proof Tat function represented a key step forward, the story remained incomplete. Thus, although CDK9 associated moter element, it encodes only a single, genome-length primary transcript. Yet expression of the nine open readwith Tat in vivo, no direct interaction between Tat and CDK9 could be demonstrated in vitro, thus making it ing frames encoded by HIV-1 requires that this single transcript be expressed in the cytoplasm as an unlikely that this interaction was indirect. Could the expected cyclin partner for CDK9 be the missing link? In spliced mRNA that serves both as the viral genome and as the mRNA for Gag and Pol-as one of five singly fact, recent data from Wei et al. (1998) demonstrate that the Tat activation domain, but not mutant forms thereof, spliced mRNAs, encoding Vif, Vpr, Vpu, and Env and lastly as one of the 16 multiply or completely spliced is able to interact directly with a protein termed cyclin T that, in turn, can bind specifically to CDK9. Importantly, mRNAs encoding Tat, Rev, and Nef. Because splicing of HIV-1 RNA transcripts is performed entirely by cellular the Tat-cyclin T complex binds to TAR with high affinity and specificity in vitro in an interaction that is dependent proteins, the generation of singly and multiply spliced viral mRNAs requires that the viral genome encode 5Ј on the integrity of not only the bulge but also the loop of TAR. Particularly satisfying is the observation that and 3Ј splice sites that can be recognized by cellular splicing factors. However, the presence of such splice cyclin T is encoded on human chromosome 12 and that overexpression of human cyclin T in mouse cells rescues sites leads to the nuclear retention of incompletely spliced viral transcripts and hence precludes expression Tat transcriptional activation via the HIV-1 TAR element. Therefore, the role of Tat appears to be to bind the cyclin of proteins encoded by the unspliced (Gag, Pol) and singly spliced (Env, Vif, Vpr, Vpu) viral mRNAs. Note T subunit of P-TEFb and to recruit P-TEFb to the HIV-1 however that HIV-1 transcripts that do not retain unutilized 5Ј splice sites, i.e. the fully spliced mRNAs encoding Tat, Rev and Nef, are not subject to nuclear retention.
To overcome this problem, HIV-1 has adopted two strategies. The first is that the splice sites present in the HIV-1 genome are designed to be inefficient. While this is not, in and of itself, sufficient to permit the nuclear export of incompletely spliced HIV-1 transcripts, it does permit a pool of such RNAs to accumulate in the nucleus. Second, HIV-1 has evolved a sequence-specific nuclear RNA export factor, termed Rev, that is able to induce the efficient nuclear export, and hence expression, of the various incompletely spliced viral transcripts (Malim et al., 1989) . Because Rev, Tat, and Nef are encoded by fully spliced HIV-1 mRNAs, these gene products are expressed shortly after infection of cells and are therefore referred to as early gene products. In contrast, the Gag, Pol, Env, Vif, Vpr, and Vpu proteins are all dependent on Rev for the nucleocytoplasmic transport of their cognate mRNAs and are therefore expressed with delayed kinetics. These six proteins are therefore referred to as late HIV-1 proteins.
The ‫611ف‬ aa Rev protein contains an arginine-rich stretch located toward the amino terminus that serves as both an ARM and as an NLS (reviewed by Cullen, 1995) . This is, in turn, closely flanked on both sides by residues that mediate Rev multimerization. Unlike the Tat ARM, the ARM present in Rev is fully able to mediate binding to its cognate RNA target site without the assis- Rev response element (RRE) encoded within the HIV-1 env gene (Malim et al., 1989) . Rev binds, most probably interact directly with nucleoporins (Mattaj and Englas a monomer, to an RNA bulge within the RRE. This meier, 1998). Binding of import factors, such as Imp ␤, initial binding event then serves to nucleate the recruitor export factors, such as Crm1, to cargo proteins is in ment of additional Rev monomers to the RRE in a multiturn regulated by the G protein Ran, which is found in merization process that requires both protein-protein the GTP-bound form in the nucleus and in the GDPand protein-RNA interactions and that is critical for Revbound form in the cytoplasm. The proposed steps in the mediated nuclear RNA export. The second functional Rev nucleocytoplasmic transport cycle are numbered in domain in Rev is an ‫01ف‬ aa leucine-rich sequence, lo- Figure 2 . cated between residues 75 and 84, that functions as a After synthesis, the Rev protein directly interacts with nuclear export signal (NES) both in Rev and when Imp ␤ via its NLS (1) (Henderson and Percipalle, 1997) . attached to other substrate proteins (Fischer et al., This is actually unusual, in that most basic NLS proteins 1995). Because Rev contains both an NLS and an NES, interact with an adaptor protein, termed Importin ␣ (Imp it rapidly shuttles back and forth between the nucleus ␣), that in turn binds to Imp ␤. In either case, Imp ␤, and the cytoplasm of expressing cells.
together with its protein cargo, is then recruited to the Initial efforts to identify a protein that mediated the nuclear pore by a direct Imp ␤-nucleoporin interaction biological activity of the Rev NES, using the yeast two-(2). The process by which translocation into the nucleohybrid assay, demonstrated a highly specific interaction plasm then occurs is unclear; however, Imp-mediated between the Rev NES and certain components of the nuclear import is known to require energy and may innuclear pore, termed nucleoporins. Because nuclear volve the ordered, sequential interaction of Imp ␤ with pores regulate all nucleocytoplasmic transport (reviewed specific nucleoporins. Once the Imp ␤-Rev NLS comby Mattaj and Englmeier, 1998) , this result was exciting plex reaches the nucleus, where Ran-GTP is present at in that it suggested that Rev might act directly to recruit high levels, the direct interaction of Imp ␤ with Ran-GTP RRE-containing RNAs to the nuclear pore and hence to results in release of the Rev cargo (3). the cytoplasm. More recently, it has become apparent The next step in the Rev pathway involves the specific that this interaction, while real, is in fact bridged by a assembly of multiple Rev molecules onto the RRE and protein, called Crm1, that is highly conserved between recruitment of Crm1 to the Rev NES sequences thereby yeast and humans (Fornerod et al., 1997; Neville et al., assembled onto the target HIV-1 transcript (4). As noted 1997; Stade et al., 1997) . Crm1 is a member of a group above, Crm1 is a member of the same family of nucleoof related proteins, of which the prototype is Importin cytoplasmic transport factors as Imp ␤ and shares a ␤ (Imp ␤), that mediate the regulated nuclear import and export of proteins and RNAs and that are known to conserved Ran-GTP-binding domain. However, while Ran-GTP binding by import factors such as Imp ␤ inthe possibility that Nef was acting as a connector between CD4 and the cellular endocytic machinery. duces the nuclear release of cargo proteins, Ran-GTP binding is a prerequisite for binding of cargo proteins
Internalization of cell surface receptors via CCPs requires the action of adaptor protein (AP) complexes that by nuclear export factors such as Crm1. The resultant ribonucleoprotein complex, consisting of the RRE RNA bind to both clathrin and either directly to the receptor itself or indirectly, via a connector protein. AP comand multiple Rev, Crm 1 and Ran-GTP molecules, is then recruited to the nuclear pore via the direct interaction plexes exist in two major varieties termed AP-1, found in the TGN, and AP-2, found at the plasma membrane. of Crm1 with nucleoporins referred to above (5). The translocation through the nuclear pore that follows is While both AP complexes are heterotetramers of similar size and structure, there are no subunits in common. again not understood, but can be viewed as the mirror image of the import translocation mediated by Imp ␤.
Analysis of the ability of Nef to interact with the various subunits of AP-1 and AP-2 has recently demonstrated Once the HIV-1 RNA cargo reaches the cytoplasm, the Ran GTPase activating protein (RanGAP), acting in conthat Nef can directly interact with both the 1 component of AP-1 and the related (40% identity) 2 compocert with Ran Binding Protein 1 (RanBP1), induces the hydrolysis of Crm1 bound Ran-GTP to Ran-GDP (6). This nent of AP-2 (Le Gall et al., 1998; Piguet et al., 1998) . As AP-2 is the adaptor present at the plasma membrane, releases both Ran and Crm1 from the Rev NES. It is unclear how Rev is released from the HIV-1 RNA, aland as internalization from the plasma membrane is the major mechanism for CD4 down-regulation, it appears though this could reflect competition from cytoplasmic Imp ␤ for binding to the Rev basic domain. At this point, probable that CD4 internalization primarily results from the recruitment of CD4 to CCPs due to the direct interacthe cargo HIV-1 RNA is available for translation of the encoded late viral protein while Rev is free to once more tion of Nef with both CD4 and the 2 subunit of AP-2. Down-Regulation of Cell Surface MHC I return to the nucleus.
In addition to CD4, Nef also induces the specific downregulation of cell-surface MHC I receptors, albeit with Nef: Numerous Effector Functions somewhat lower efficiency (Le Gall et al., 1998) . MHC I The third early protein encoded by HIV-1, termed Nef, down-regulation results from both the internalization of is not only the largest auxiliary protein, at ‫602ف‬ aa in cell-surface MHC I receptors and from the sorting of length, but is also expressed in far higher levels than MHC I molecules from the TGN into AP-1-containing Tat and Rev. Nevertheless, Nef was initially found to clathrin-coated vesicles. This down-regulation requires exert a quite modest effect on the rate of HIV-1 replicaspecific sequences in the MHC I cytoplasmic tail includtion in culture, with some early reports even suggesting ing a key tyrosine residue (Greenberg et al., 1998 ; Le that Nef was a negative factor. However, the subsequent Gall et al., 1998) . No leucine motif, similar to that required demonstration that inactivation of the nef gene in a for CD4 down-regulation, exists in MHC I. pathogenic clone of simian immunodeficiency virus (SIV)
Because MHC I is required to present viral peptide caused a dramatic drop in both viral titer and pathogenic epitopes to cytotoxic T lymphocytes (CTL), down-regupotential in infected macaques, revealed that Nef was lation of cell surface MHC I could inhibit the CTL-medicritically important in vivo (Kestler et al., 1991) . More ated lysis of HIV-1-infected cells, and this has indeed recent research has demonstrated that Nef exerts at been recently demonstrated (Collins et al., 1998) . Alleast three distinct activities in infected cells. though this result might suggest that MHC I down-reguDown-Regulation of Cell Surface CD4 lation is the major contributor to the in vivo Nef phenoThe first clear activity to be assigned to Nef was downtype, this may not be the case as a clear positive effect regulation of cell surface CD4 expression (Garcia and of Nef on viral replication in vivo is seen in SIV-infected Miller, 1991) . CD4 is the primary receptor for HIV-1 and macaques by two weeks after infection (Kestler et al., down-regulation would therefore be predicted to reduce 1991), i.e., before an effective CTL response can be the formation of complexes between CD4 and newly mounted by the infected animal. The fact that a readily synthesized HIV-1 Envelope protein on the infected cell detectable anti-HIV-1 CTL response is observed in most surface and also to facilitate the release of HIV-1 virions infected individuals (reviewed by McMichael, 1998 [this (Benson et al., 1993 . The Nef protein is posttranslaissue of Cell]) further demonstrates that the Nef-meditionally modified by myristoylation of its amino terminus, ated inhibition of antigen presentation via MHC I is and this modification targets Nef to the inner surface of clearly incomplete. the plasma membrane and to the trans-Golgi network Analysis of the Nef protein demonstrates that CD4 (TGN). It is believed that Nef binds the cytoplasmic tail and MHC I down-regulation can be, at least in part, of CD4 directly, although this remains to be fully proven.
mutationally segregated (Greenberg et al., 1998) . HowDownregulation of cell surface CD4 is a specific event ever, as the cytoplasmic tails of CD4 and MHC I display requiring a cluster of leucine and isoleucine residues in no sequence homology, this segregation could simply the CD4 cytoplasmic tail and results from the targeting reflect the selective disruption of the MHC I and CD4 of CD4 into clathrin coated pits (CCPs) followed by intertargeting functions of Nef. At present, the simplest internalization and transport to lysosomes, where CD4 is pretation of the available data is that Nef connects both degraded (Aiken et al., 1994) . Direct fusion of Nef to CD4 and MHC I to the intracellular protein sorting mathe extracellular and transmembrane domains of CD4 chinery by binding to CD4 or MHC I on the one hand recapitulates the phenotype seen when Nef is expressed and either AP-1 or AP-2 on the other. Regardless of in trans, i.e. the CD4-Nef fusion protein is also internalwhether AP-1 or AP-2 is recruited, which may largely depend on whether recruitment occurs at the TGN or ized via CCPs and degraded. This observation raised at the plasma membrane, these target proteins are then effect of Nef on cellular activation represents an independent phenotype or whether this is likely to be imporsorted into clathrin-coated vesicles that deliver them for degradation in lysosomes. tant in vivo.
In conclusion, it is clear that Nef exhibits a number Enhanced Virion Infectivity In addition to a possible enhancement in virion infectivity of distinct activities that undoubtedly each contribute to the marked increase in viral replication and pathogedue to CD4 down-regulation, Nef also enhances virion infectivity by a second, entirely CD4-independent mechnicity displayed by Nef expressing HIV-1 and SIV in vivo.
Definition of the precise contribution of each activity to anism (Spina et al., 1994) . This enhancement is conferred by Nef during the process of virion assembly and the overall in vivo phenotype will require a far more complete understanding of the domain organization of cannot be complemented by expression of Nef in target cells. While the effect of Nef on virion infectivity is quite Nef than currently exists. Once this is achieved, it may then be possible to design mutations that selectively modest in most culture settings, this effect may increase to 10-fold or more when primary T cells are infected inactivate specific Nef functional domains and then assess their effect on viral replication and pathogenesis with HIV-1 while quiescent and then subsequently activated or if certain highly susceptible target cells, such in vivo. as CD4
ϩ -HeLa cells, are used. While HIV-1 virions produced in the presence and
Vif: Virion Infectivity Factor
The Vif protein is encoded by a singly spliced mRNA absence of Nef do not differ in terms of cell-free reverse transcriptase activity or in terms of their ability to bind whose expression is Rev dependent, and Vif is therefore a late HIV-1 gene product. Vif is ‫291ف‬ aa in length and to and enter target cells, they are less able to complete proviral DNA synthesis. While Nef does not cause any is expressed at high levels in the cytoplasm of infected cells. A substantial fraction of Vif is membrane associmajor change in the morphology or composition of virions, two differences have been reported. First, Nef itself ated and colocalizes with the HIV-1 Gag protein, a property that is likely to be important for its biological activity. is packaged into virions at low efficiency (Յ10 molecules per virion) and even undergoes specific processing by
The only known biological activity of Vif is to enhance the infectivity of HIV-1 virions produced in primary T the HIV-1 protease. While this finding may be important, it could also simply reflect a low level of nonspecific cells, and in "nonpermissive" cell lines such as H9, by ‫-001ف‬fold (Gabuzda et al., 1992) . In contrast, virions packaging of the membrane-associated Nef protein into virions during viral budding from the cell membrane. It produced in "permissive" cell lines such as CEM-SS are equivalently infectious whether Vif is present or not. It has also been reported that serine phosphorylation of the matrix component of HIV-1 Gag is modified in Nefremains unclear whether this phenomenon reflects the presence of an inhibitor of viral replication in nonpermisexpressing cells. Nef has previously been reported to associate specifically with a serine kinase related to sive cells that is inactivated by Vif or, alternately, the existence of a factor in permissive cells that substitutes p21-activated kinase (PAK), and it is therefore possible that Nef may recruit a PAK-like kinase to sites of virion for Vif. The nonpermissive state appears most physiologically relevant, both because this is the phenotype assembly (Swingler et al., 1997) . While a Nef-induced change in the phosphorylation state of matrix could cerof primary cells in culture and because vif Ϫ SIV replicates extremely poorly in vivo. tainly affect virion infectivity, this hypothesis remains to be proven.
Vif-enhanced infectivity is conferred in the virus-producing cell yet only manifests itself in the target cell.
Effects on Cellular Signal Transduction and Activation
vif Ϫ proviruses can therefore be complemented in trans in virus-producing cells but not in target cells. Analysis While there have been number of reports documenting effects of Nef on signal transduction pathways and on of HIV-1 virions produced by nonpermissive cells in the presence and absence of Vif has failed to document any the activation state of both lymphoid and nonlymphoid cells, no clear consensus exists as to cellular targets or quantitative or qualitative difference in the incorporation or processing of viral structural proteins, although there even as to whether the effect of Nef is positive or negative. Clearly, the possibility exists that these reported are reports suggesting that vif Ϫ viruses are more likely to exhibit an aberrant morphology. One clear difference effects are entirely secondary to the more fully documented properties of Nef listed above. For example, is that between 10 and 100 molecules of Vif are packaged into virions produced in the presence of Vif. While Nef-induced degradation of CD4 is known to result in the release of the normally CD4-bound tyrosine kinase this incorporation could certainly be important for the Vif phenotype, it remains uncertain whether this incorpolck, and this could have a marked effect on signaling via, for example, the TCR/CD3 complex. In addition, Nef ration is specific as murine leukemia virus, which lacks a protein equivalent to Vif, is able to package Vif with is believed to recruit a serine/threonine kinase related to PAK to the plasma membrane and also contains an comparable efficiency (Camaur and Trono, 1996) . There is general agreement that defective vif Ϫ virions SH3-binding motif that could interact with membranebound tyrosine kinases or other signaling molecules. By can bind to, and penetrate into, target cells effectively and are also able to initiate reverse transcription (Simon juxtaposing enzymes and proteins that are not normally in contact, Nef may either inadvertently or intentionally and Malim, 1996) . There is also general agreement that reverse transcription fails to go to completion, although modulate the activation state of the cell. At present, the assays used to measure these effects, and the range of there is some controversy as to the precise stage at which failure occurs. In any event, although the preinteNef mutants that have been analyzed, do not permit any clear statement to be made as to whether the reported gration complex (PIC) reaches the nucleus, little or no full-length provirus is produced and the partial reverse interaction of Vpr with nucleoporins and Imp ␣ appears likely to be critical for its role in HIV-1 PIC nuclear import transcripts that are synthesized are rapidly degraded. It therefore appears that Vif, acting in the virus-producing and, hence, in enhancing HIV-1 replication in macrophages and other nondividing cells. cells, somehow modifies HIV-1 virions in a way that confers enhanced postpenetration stability and function
In addition to its role in nuclear import, Vpr has a second, distinct activity in expressing cells, induction on PICs in target cells.
Although no cellular target for Vif is as yet known, of arrest in the G2 phase of the cell cycle, that maps to an ‫62ف‬ aa carboxy-terminal basic domain. Cells exrecent data demonstrate that such a target must exist (Simon et al., 1998) . Specifically, while HIV-1 Vif can pressing Vpr contain very low levels of p34 cdc2 -cyclin B kinase activity, although both proteins are expressed complement the infectivity of vif Ϫ HIV-1 and SIV AGM virions produced in nonpermissive human cells, SIVAGM Vif (Re et al., 1995) . The activity of the p34 cdc2 -cyclin B kinase is critical for the transition from G2 to mitosis and is inactive. In contrast, SIVAGM Vif can complement vif Ϫ HIV-1 and SIVAGM produced in simian cells, while HIV-1 requires the removal, by the phosphatase cdc25C, of phosphate residues on p34 cdc2 that inhibit kinase funcVif is inactive. These data not only demonstrate that Vif function is dependent on the presence of a cellular tion. However, in Vpr-expressing cells, cdc25C is in an inactive form, thus suggesting that the target for Vpr cofactor but also reveal that different immunodeficiency virus Vif proteins have evolved a considerable degree function is likely to be an upstream regulator of the G2 to M transition. of primate species specificity. This result is of interest given current efforts to develop simian and murine modAn interesting rationale for the Vpr-mediated arrest of cells in G2 is provided by the recent observation that els that can support a high-titer, pathogenic infection by HIV-1.
the HIV-1 LTR promoter is more active in G2-arrested cells (Goh et al., 1998) . Arrest of cells in G2 by either Vpr or by overexpression of a dominant negative form Vpr: Nuclear Import and G2 Arrest of p34 cdc2 , was shown to activate the HIV-1 LTR promoter The Vpr protein is a late HIV-1 gene product of ‫69ف‬ aa to an equivalent degree. Therefore, the mild stimulatory in length that is packaged into the virion nucleocapsid effect of Vpr on the LTR promoter, which had been noted in molar amounts equivalent to those of the Gag protein.
previously by others, is likely to be entirely indirect. The Vpr may therefore be viewed as a virion structural proimportance of this enhancement is, however, unclear tein. Packaging into virions is mediated by the p6 progiven that the effect of Vpr on the rate of HIV-1 replication tein, located at the very carboxy terminus of the p55 in rapidly dividing T cells in culture, which should be Gag precursor, and also requires specific sequences highly responsive to G2 arrest, is minor (Heinzinger et located toward the center of Vpr (Paxton et al., 1993 (Paxton et al., ). al., 1994 Vodicka et al., 1998) . Analysis of the effect of Vpr on HIV-1 replication demonstrated a modest positive effect in T cell lines and primary T cells but a far more marked effect on HIV-1 Vpu: Unique to HIV-1 While the other auxiliary proteins of HIV-1 are conserved replication in growth-arrested cells, such as primary macrophages. This effect is thought to reflect an imporin some or all of the animal lentiviruses (Tat, Rev, and Vif) or at least in all primate immunodeficiency viruses tant role for Vpr in mediating the nuclear import of HIV-1 PICs into the nucleus of, particularly, nondividing cells (Nef and Vpr), Vpu appears unique to HIV-1 and the closely related SIVcpz isolates. Vpu is an oligomeric inte- (Heinzinger et al., 1994) . Nuclear import of HIV-1 PICs is an active process that is believed to require an array gral membrane protein consisting of an amino-terminal transmembrane domain and a carboxy-terminal cytoof NLS sequences provided by the matrix protein, by integrase, and also by Vpr. The Vpr NLS, which extends plasmic tail. Vpu serves two independent functions in the HIV-1 life cycle: enhancement of virion release from over essentially the entire amino-terminal 70 aa of Vpr, is a nonconventional NLS, i.e., distinct from the basic infected cells and the selective degradation of CD4 in the cell endoplasmic reticulum (ER). NLS prototype. Interestingly, fusion of a carrier protein, such as ␤-gal, to the Vpr NLS induces not only nuclear Simultaneous synthesis of both HIV-1 envelope and CD4 in a single cell results in the formation of Env-CD4 import, but also a marked accumulation of the fusion protein at nuclear pores (Vodicka et al., 1998) . A search complexes in the ER that are retained and eventually degraded. Vpu directly interacts with a specific target for potential cellular target proteins for Vpr has demonstrated that Vpr can directly interact with a subset of sequence in the cytoplasmic tail of CD4, distinct from that seen by Nef, to target CD4 to an ER-associated nucleoporins, thus potentially explaining this localization. In addition, Vpr can also bind to Imp ␣, the adaptor protein degradation pathway. This permits the release of Env from the ER and its subsequent incorporation protein that normally mediates the interaction of basic NLS sequences with the Imp ␤ nuclear import factor into progeny virions (Willey et al., 1992) . The mechanism by which Vpu targets CD4 for prote- (Mattaj and Englmeier, 1998) . However, the binding sites for Vpr and basic NLSs on Imp ␣ are distinct and this olysis has recently been resolved (Margottin et al., 1998) . Vpu, via its cytoplasmic tail, binds to CD4 molecules interaction is not believed to recruit Vpr to Imp ␤ (Popov et al., 1998) . While the reason for the interaction of Vpr that have been retained in the ER and also recruits a cellular factor termed h-␤TrCP to the ER membrane. with Imp ␣ is therefore uncertain, it has been proposed that it could enhance the affinity of Imp ␣ for basic NLSs
The h-␤TrCP protein consists of a series of WD repeat elements, which bind Vpu, and a so-called F box, which present on HIV-1 PICs, and thereby enhance PIC import into the nucleus (Popov et al., 1998 for degradation, most probably by the proteasome, Cell 82, [475] [476] [477] [478] [479] [480] [481] [482] [483] while Vpu is apparently recycled (Margottin et al., 1998 retroviruses. Little is known as to the mechanism re-
